These 11 stocks hit 52-week lows, fell up to 50% in a month
Consistent winners! 9 stocks gain at least 25% in last four quarters, turn multibaggers
Corporate actions this week: Gujarat Themis Biosyn to go ex-split, RMC Switchgear ex-bonus and moreNo Data Available
Gujarat Themis Biosyn Share Price
Loading...
| Open | 402.50 |
| High | 410.90 |
| Low | 397.05 |
| Prev Close | 402.30 |
| Volume | 7,17,526 |
| VWAP(₹) | 400.95 |
Key Metrics
| PE Ratio(x) | 93.47 |
| EPS - TTM(₹) | 4.28 |
| MCap(₹ Cr.) | 4,363.51 |
| MCap Rank | 64 |
| PB Ratio(x) | 15.23 |
| Div Yield(%) | 0.17 |
| Face Value(₹) | 1.00 |
| 52W High(₹) | 479.00 |
| 52W Low(₹) | 225.05 |
| MCap/Sales | 14.95 |
| Beta(1 Month) | - |
| BV/Share(₹) | 26.41 |
Gujarat Themis share price insights
Board Meeting was held on Jun 19, 2026
Meeting Agenda: To consider Fund Raising. Please add to watchlist to track closely.Passing Profits to Shareholders
Company has consistently declining ROE in last 5 years. Majority of profits last year were disbursed as dividends to shareholders. (Source: Standalone Financials)Employee & Interest Expense
Company has spent 1.78% of its operating revenues towards interest expenses and 9.96% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)Gujarat Themis Share Price Update
Gujarat Themis Biosyn Ltd. share price moved down by -0.46% from its previous close of Rs 402.30. Gujarat Themis Biosyn Ltd. stock last traded price is 400.45
Share Price Value Today/Current/Last 400.45 Previous Day 402.30
Found Insights useful?
Gujarat Themis Share Price Returns
| 1 Day | -0.46% |
| 1 Month | 8.61% |
| 3 Months | 55.03% |
| 1 Year | 23.29% |
| 3 Years | N.A. |
| 5 Years | N.A. |
Gujarat Themis Share Recommendations
Recent Recos
- Target₹909
- OrganizationHDFC Securities
- BUY
News & Analysis
Financials
Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Total Income 45.15 43.78 43.17 36.15 39.08 Total Income Growth (%) 3.13 1.43 19.41 -7.51 -1.70 Total Expenses 28.91 25.95 24.36 23.99 22.93 Total Expenses Growth (%) 11.41 6.51 1.58 4.62 3.19 EBIT 16.24 17.83 18.80 12.16 16.16 EBIT Growth (%) -8.92 -5.14 54.59 -24.73 -7.90 Profit after Tax (PAT) 10.89 12.46 14.26 9.06 12.00 PAT Growth (%) -12.62 -12.61 57.41 -24.47 -7.51 EBIT Margin (%) 35.97 40.73 43.56 33.64 41.34 Net Profit Margin (%) 24.12 28.47 33.05 25.07 30.70 Basic EPS (₹) 1.00 1.14 1.31 0.83 1.10 All figures in Rs Cr, unless mentioned otherwise
InsightsEmployee & Interest Expense
Company has spent 1.78% of its operating revenues towards interest expenses and 9.96% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)
Annual FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 Total Assets 503.43 301.31 221.11 166.33 122.50 Total Assets Growth (%) 67.08 36.27 32.93 35.78 38.79 Total Liabilities 215.67 52.93 19.74 17.18 19.18 Total Liabilities Growth (%) 307.46 168.14 14.90 -10.43 4.69 Total Equity 287.76 248.38 201.38 149.15 103.32 Total Equity Growth (%) 15.85 23.34 35.02 44.36 47.71 Current Ratio (x) 1.12 2.53 2.94 3.98 4.57 Total Debt to Equity (x) 0.56 0.12 0.00 0.00 0.00 Contingent Liabilities 0.00 9.88 10.60 21.14 6.64 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 Net Cash flow from Operating Activities 48.78 91.03 64.21 39.50 40.31 Net Cash used in Investing Activities -172.28 -111.82 -55.21 -20.41 -29.83 Net Cash flow from Financing Activities 114.93 26.01 -8.59 -13.30 -14.00 Net Cash Flow -8.57 5.22 0.41 5.79 -3.51 Closing Cash & Cash Equivalent 3.12 11.69 6.47 6.06 0.46 Closing Cash & Cash Equivalent Growth (%) -73.31 80.76 6.84 1,214.02 -88.41 Total Debt/ CFO (x) 3.28 0.33 0.00 0.00 0.00 All figures in Rs Cr, unless mentioned otherwise
InsightsIncrease in Cash from Investing
Company has used Rs 172.28 cr for investing activities which is an YoY increase of 54.07%. (Source: Standalone Financials)
Annual FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 Return on Equity (%) 16.22 19.63 29.37 38.86 42.22 Return on Capital Employed (%) 15.32 23.47 38.82 51.41 56.82 Return on Assets (%) 9.27 16.18 26.75 34.85 35.61 Interest Coverage Ratio (x) 26.44 195.82 362.56 399.81 75.01 Asset Turnover Ratio (x) 0.41 0.58 0.88 1.03 1.09 Price to Earnings (x) 53.19 62.89 48.78 17.21 13.59 Price to Book (x) 8.61 12.35 14.29 6.69 5.73 EV/EBITDA (x) 33.76 43.28 34.53 12.31 9.33 EBITDA Margin (%) 47.01 47.26 48.93 53.86 54.06 InsightsPassing Profits to Shareholders
Company has consistently declining ROE in last 5 years. Majority of profits last year were disbursed as dividends to shareholders. (Source: Standalone Financials)
Found Financials useful?
Technicals
No Data Available
R1 - Pivot -
S1 - R2 - S2 - R3 - S3 - 5 Days 14 Days 28 Days - - -
Peer Comparison
- 1D
- 1W
- 1M
- 3M
- 6M
- 1Y
- 5Y
Choose from Peers
Choose from Stocks
Mutual Funds Ownership
MF Ownership as on 31 May 2026
Quant Manufacturing Direct-G
Equity: Thematic-Manufacturing40.27
Amount Invested (in Cr.)
5.67242%
% of AUM
0.00
% Change (MoM basis)
10.43
Amount Invested (in Cr.)
0.561001%
% of AUM
0.00
% Change (MoM basis)
Motilal Oswal BSE Healthcare ETF-G
Equity: Sectoral-Pharma0.03
Amount Invested (in Cr.)
0.09%
% of AUM
-9.45
% Change (MoM basis)
Gujarat Themis Top Searches
Corporate Actions
Board Meeting
To consider Fund Raising
Jun 18, 2026
Board Meeting
Fund Raising & Others
Jun 04, 2026
Final
67%
May 25, 2026
Announced on Meeting on Jun 18, 2026 Jun 19, 2026 To consider Fund Raising Jun 04, 2026 Jun 06, 2026 Fund Raising & Others May 19, 2026 May 25, 2026 Audited Results, Dividend & Others Jan 30, 2026 Feb 05, 2026 Quarterly Results Nov 04, 2025 Nov 10, 2025 Quarterly Results Announced on Ex-Date Dividend% May 20, 2025 Sep 04, 2025 67% May 14, 2024 Jul 15, 2024 25% Feb 12, 2024 Feb 22, 2024 75% May 15, 2023 Sep 01, 2023 20% May 25, 2026 - 67% Announced on Ex-Date May 14, 2024 Aug 09, 2024 Bonus Ratio: 1 share(s) for every 2 shares held Announced on Ex-Date May 13, 2023 Oct 10, 2023 Split: Old FV5.0| New FV:1.0 No Data Available
Announced on Meeting on May 06, 2026 Jun 08, 2026 - Mar 18, 2026 Apr 21, 2026 - Jan 07, 2026 Feb 08, 2026 - Aug 20, 2025 Sep 12, 2025 - Sep 17, 2024 Oct 15, 2024 -
About Gujarat Themis
Gujarat Themis Biosyn Ltd., incorporated in the year 1981, is a Small Cap company (having a market cap of Rs 4,363.51 Crore) operating in Pharmaceuticals sector.
Show More
Industry
Key Indices Listed On
BSE SmallCap, BSE Healthcare, BSE AllCap, BSE MidSmallCap
Address
Plot NO. 69-C,G.I.D.C.,Industrial Estate,Valsad District, Gujarat - 396195
Executive Leadership
DS
Dinesh S Patel
Non Executive ChairmanSD
Sachin D Patel
Managing DirectorHD
Hitesh D Gajaria
Independent DirectorKG
K G Ananthakrishnan
Independent DirectorShow More
Auditors
GMJ & Co
Top Gainers
As on 03:59 PM | 23 Jun 2026Top Losers
As on 03:59 PM | 23 Jun 2026Trending in Markets
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.